You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial

Article info

Article menu

Download PDFPDF

Treatments
Original research
Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial

Authors

  • E Michael Shanahan Rheumatology, Flinders Medical Centre, Adelaide, South Australia, AustraliaRheumatology, College of Medicine and Public Health, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Tiffany K Gill The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, AustraliaSouth Australian Health and Medical Research Institute Limited, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Elizabeth Briggs Rheumatology, Flinders Medical Centre, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Catherine L Hill Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Gregory Bain Orthopaedic Department, College of Medicine and Public Health, Bedford Park, South Australia, Australia PubMed articlesGoogle scholar articles
  • Timothy Morris Physiotherapy Department, Flinders University College of Nursing and Health Sciences, Bedford Park, South Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor E Michael Shanahan; michael.shanahan{at}sa.gov.au
View Full Text

Citation

Shanahan EM, Gill TK, Briggs E, et al
Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial
RMD Open 2022;8:e002648. doi: 10.1136/rmdopen-2022-002648

Publication history

  • Received August 8, 2022
  • Accepted October 14, 2022
  • First published November 23, 2022.
Online issue publication 
November 23, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.